Ambica International Corporation Promeddazole Metronidazole Филипини - английски - FDA (Food And Drug Administration)

ambica international corporation promeddazole metronidazole

akums drugs & pharmaceuticals ltd. (plant iii-injectables) - drug - metronidazole - promeddazole

Sugammadex Pharmazac Solution for Injection 100mg/ml (2ml vial) Малта - английски - Medicines Authority

sugammadex pharmazac solution for injection 100mg/ml (2ml vial)

pharmazac, s.a. 31 naousis str., 104 47, athens,, greece - sugammadex - solution for injection - sugammadex 200 mg - all other therapeutic products

Sugammadex Pharmazac Solution for Injection 100mg/ml (5ml vial) Малта - английски - Medicines Authority

sugammadex pharmazac solution for injection 100mg/ml (5ml vial)

pharmazac, s.a. 31 naousis str., 104 47, athens,, greece - sugammadex - solution for injection - sugammadex 500 mg - all other therapeutic products

Aripiprazole Mylan Pharma (previously Aripiprazole Pharmathen) Европейски съюз - английски - EMA (European Medicines Agency)

aripiprazole mylan pharma (previously aripiprazole pharmathen)

mylan pharmaceuticals limited - aripiprazole - schizophrenia; bipolar disorder - psycholeptics - aripiprazole mylan pharma is indicated for the treatment of schizophrenia in adults and in adolescents aged 15 years and older.aripiprazole mylan pharma is indicated for the treatment of moderate to severe manic episodes in bipolar i disorder and for the prevention of a new manic episode in adults who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment.aripiprazole mylan pharma is indicated for the treatment up to 12 weeks of moderate to severe manic episodes in bipolar i disorder in adolescents aged 13 years and older.

MAYNE PHARMA OXYCODONE  IR oxycodone hydrochloride 5 mg tablet blister pack Австралия - английски - Department of Health (Therapeutic Goods Administration)

mayne pharma oxycodone ir oxycodone hydrochloride 5 mg tablet blister pack

mayne pharma international pty ltd - oxycodone hydrochloride, quantity: 5 mg - tablet - excipient ingredients: microcrystalline cellulose; sodium starch glycollate type a; silicon dioxide; lactose monohydrate; maize starch; stearic acid - mayne pharma oxycodone ir is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.